News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
34,836 Results
Type
Article (3122)
Company Profile (12)
Press Release (31702)
Section
Business (11677)
Career Advice (100)
Deals (1319)
Drug Delivery (5)
Drug Development (3471)
Employer Resources (4)
FDA (575)
Job Trends (769)
News (17000)
Policy (1195)
Tag
Academia (419)
Alliances (3967)
Alzheimer's disease (46)
Approvals (575)
Artificial intelligence (13)
Bankruptcy (17)
Best Places to Work (531)
Biotechnology (8)
Cancer (33)
Career advice (89)
Career pathing (4)
Cell therapy (15)
Clinical research (2526)
Collaboration (23)
COVID-19 (257)
C-suite (3)
Cystic fibrosis (11)
Data (24)
Diagnostics (480)
Drug discovery (8)
Earnings (2123)
Events (3899)
Executive appointments (18)
FDA (586)
Funding (21)
Gene therapy (9)
GLP-1 (23)
Government (317)
Healthcare (733)
Immunology and inflammation (4)
Infectious disease (262)
Inflammatory bowel disease (5)
Interviews (11)
IPO (490)
Job creations (246)
Job search strategy (84)
Layoffs (22)
Legal (160)
Liver cancer (4)
Manufacturing (12)
Medical device (649)
Medtech (649)
Mergers & acquisitions (821)
Metabolic disorders (9)
Neuroscience (54)
NextGen Class of 2024 (325)
Non-profit (363)
Northern California (40)
Obesity (5)
Opinion (15)
People (4470)
Phase I (921)
Phase II (1171)
Phase III (769)
Pipeline (7)
Policy (6)
Postmarket research (57)
Preclinical (495)
Press Release (23)
Radiopharmaceuticals (5)
Rare diseases (14)
Real estate (555)
Regulatory (778)
Reports (4)
Research institute (435)
Resumes & cover letters (11)
Series A (4)
Southern California (25)
Startups (373)
United States (476)
Vaccines (25)
Date
Today (6)
Last 7 days (21)
Last 30 days (119)
Last 365 days (1607)
2024 (1303)
2023 (1924)
2022 (2777)
2021 (2948)
2020 (3046)
2019 (2412)
2018 (1929)
2017 (2180)
2016 (1989)
2015 (2338)
2014 (1690)
2013 (1529)
2012 (1214)
2011 (1408)
2010 (1240)
Location
Africa (49)
Asia (2730)
Australia (569)
California (81)
Canada (37)
China (15)
Colorado (4)
Europe (4651)
Florida (9)
Georgia (20)
Illinois (7)
Indiana (5)
Kansas (7)
Maryland (27)
Massachusetts (68)
Michigan (5)
Minnesota (29)
Missouri (11)
New Jersey (51)
New York (38)
North Carolina (21)
Northern California (40)
Ohio (9)
Pennsylvania (31)
South America (60)
Southern California (25)
Texas (15)
Virginia (8)
Washington State (21)
34,836 Results for "humabs biomed".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
BioMed X Start Collaboration in Autoimmunity Research with Servier
The new research team at the BioMed X Institute in Heidelberg will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.
June 26, 2024
·
3 min read
Business
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its first quarter 2024 financial results and provided a business update.
May 13, 2024
·
13 min read
Business
BioMed X Launches New US Institute in New Haven, CT
Connecticut Governor Ned Lamont, New Haven Mayor Justin Elicker, and Josh Geballe, Managing Director of Yale Ventures, participated in the launch ceremony of the new BioMed X Institute on Tuesday, June 11, 2024.
June 13, 2024
·
3 min read
Pharm Country
Psyence Biomed to Participate in the A.G.P. Virtual Healthcare Company Showcase
Psyence Biomedical Ltd (Nasdaq:PBM) (“Psyence Biomed” or the “Company”) today announced that management will host 1x1 meetings with investors during the A.G.P. Virtual Healthcare Company Showcase, which is being held May 21, 2024.
May 17, 2024
·
1 min read
Job Trends
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg
BioMed X, a German biomedical research institute, announces the start of a new research project in partnership with Merck at its site in Heidelberg, Germany.
April 30, 2024
·
2 min read
Biotech Bay
BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project
German independent research institute BioMed X announces the successful completion of its second neuroscience project in partnership with Boehringer Ingelheim in the field of psychiatric disorders.
May 28, 2024
·
3 min read
Press Releases
Psyence Biomed Enters into Agreement to Acquire Stake in PsyLabs
September 19, 2024
·
7 min read
Pharm Country
Orchestra BioMed to Participate in Jefferies 2024 Global Healthcare Conference
Orchestra BioMed Holdings, Inc. announced that company management will present and be available for one-on-one meetings at the Jefferies Global Healthcare Conference being held in New York, NY, June 4-6, 2024.
May 22, 2024
·
1 min read
Biotech Bay
Mainz Biomed Reports Results of 2024 Annual General Meeting
Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, held its annual general meeting on Friday, May 31, 2024 in Amsterdam, The Netherlands.
May 31, 2024
·
5 min read
Lone Star Bio
Texas Biomed researching vaccines and treatments for highly pathogenic avian influenza
Researchers at Texas Biomedical Research Institute (Texas Biomed) are studying potential vaccines, antivirals and antibodies against highly pathogenic avian influenza, including H5N1 strains that closely mirror the one recently detected in cows, chickens and one person in Texas.
April 18, 2024
·
3 min read
1 of 3,484
Next
